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Abstract
A cytochrome P450 (CYP) enzyme, 3’-daidzein hydroxylase, CYP105D7 (3’-DH), responsible for daidzein
hydroxylation at the 3’-position, was recently reported. CYP105D7 (3’-DH) is a class I type of CYP that requires
electrons provided through electron transfer proteins such as ferredoxin and ferredoxin reductase. Presently, we
constructed an artificial CYP in order to develop a reaction host for the production of a hydroxylated product.
Fusion-mediated construction with the reductase domain from self-sufficient CYP102D1 was done to increase
electron transfer efficiency and coupling with the oxidative process. An artificial self-sufficient daidzein hydroxylase
(3’-ASDH) displayed distinct spectral properties of both flavoprotein and CYP. The fusion enzyme catalyzed
hydroxylation of daidzein more efficiently, with a kcat/Km value of 16.8 μM-1 min-1, which was about 24-fold higher
than that of the 3’-DH-camA/B reconstituted enzyme. Finally, a recombinant Streptomyces avermitilis host for the
expression of 3’-ASDH and production of the hydroxylated product was developed. The conversion that was
attained (34.6%) was 5.2-fold higher than that of the wild-type.
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Introduction
Cytochrome P450 monooxygenases (CYPs) are a super-
family of heme-thiolate containing enzymes that catalyze
a variety of chemical reactions in regio/stereo-selective
manners [1]. Various types of reactions catalyzed by
CYP have been identified; generally, these enzymes act
as monooxygenases that catalyze the introduction of an
oxygen molecule into the substrate whereby one atom of
molecular oxygen is incorporated into the product [2].
Oxidation is one of the most valuable reactions in mod-
ern industrial processes involving drug development and
bio-fuel generation, and is the most common P450-
catalyzed reaction for both endogenous and exogenous
compounds [3,4].
Fundamentally, the CYP-catalyzed oxidation reaction
requires the sequential input of two electrons and two
protons ([P450-RH] + 2 e- + 2 H+ + O2!P450 +ROH+
H2O) in the presence of oxygen to activate a R-H bond,
followed by the release of the hydroxylated product, R-
OH, and water [5]. CYPs require a tight interaction with
auxiliary proteins, electron transferring proteins from a
cofactor. The combination and orientation of redox pro-
teins classifies CYPs into several types [6-8]. Among
them, especially, the class III cytochrome P450 system
consists of a self-sufficient CYP, in which the heme do-
main is fused with a P450 reductase domain and encoded
in a single polypeptide [9,10]. Several self-sufficient
P450s belonging to the CYP102A family, as well as
CYP102D1, have been identified from the genome
sequences of various Bacillus species such as CYP102A2
and CYP102A3 from Bacillus subtilis, CYP102A5 from
B. cereus and CYP102A7 from B. licheniformis, and re-
cently, CYP102D1 was identified from Streptomyces aver-
mitilis [11-15]. Especially, the fusion arrangement as
self-sufficient CYPs enhances catalytic efficiency, in
* Correspondence: hypark@snu.ac.kr; byungkim@snu.ac.kr
1School of Chemical and Biological Engineering, Institute of Bioengineering,
Seoul National University, Seoul, South Korea
4Korea Bio-Hub Center, Bio-MAX Institute, Seoul National University, Seoul,
South Korea
Full list of author information is available at the end of the article
© 2012 Choi et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Choi et al. Microbial Cell Factories 2012, 11:81
http://www.microbialcellfactories.com/content/11/1/81
terms of the kinetic parameters kcat and Km [16]. For ex-
ample, CYP102A1 BM3 catalyses fatty acid hydroxylation
at rates of up to approximately17,000 min-1, which is at
least two orders of magnitude faster than observed for
other class I type fatty acid hydroxylases [6,17]. The
knowledge that self-sufficient P450s exhibit the highest
turnover frequency due to the higher possibility of con-
tact between the heme and reductase domains, and the
induction of intra-molecular electron transfer, have
prompted several attempts to make an artificial self-
sufficient system by fusing redox proteins. In one study,
the N-terminally modified human P450s CYP2C9,
CYP2C19 and CYP3A4 fused to the soluble NADPH-
dependent oxidoreductase domain of CYP102A1 were
constructed to exploit the advantages of the fused nature
of the bacterial CYP102A1 system [18]. Also, P450cam
from Pseudomonas putida (CYP101A) and P450bzo from
an environmental metagenome library (CYP203A) were
fused with the reductase domain of self-sufficient
P450RhF from Rhodococcus sp. NCIMB 9784 to increase
catalytic efficiency [19].
Recently our group reported two enzymes, CYP105D7
(3’-DH), which is especially responsible for daidzein hy-
droxylation at the 3’-position of the daidzein B-ring
with very high regio-selectivity, and CYP102D1, a
unique self-sufficient P450 from S. avermitilis [15,20].
The 3’-DH encoded by sav7469 from S. avermitilis cat-
alyzes the hydroxylation of daidzein to produce 3’,4’,7-
trihydroxyisoflavone (3’-ODI) and is a class I CYP,
which are necessary electron transfer proteins. CYP102D1
is also a promising model for the construction of an artifi-
cial self-sufficient CYP with 3’-DH. Here, we demonstrate
the fusion-mediated arrangement of 3’-DH that was
achieved by engineering a class I type of CYP into an artifi-
cial self-sufficient CYP to increase enzyme catalytic activity
and the bio-conversion of daidzein (Figure 1).
Furthermore, P450 systems are especially well-
developed in Streptomyces strains producing various
kinds of secondary metabolites, such as antibiotics that
are in most cases regulated by P450 systems at the last
step. Many of these systems bestow potent biological ac-
tivities [21]. Especially, S. avermitilis produces 33 P450
enzymes that are valuable as extra- or intra-cellular
enzymes capable of catalyzing targeting molecules, as
well as more than half of the known biologically active
microbial products, including many commercially import-
ant antibiotics, immunosuppressive compounds, animal
health products and agrochemicals [22]. This vast reservoir
of diverse products has made S. avermitilis one of the most
important industrial microbial genera. A battery of tool for
the genetic manipulation of the organism is available [23].
Presently, with the goal of constructing a versatile model
host for the biotransformation of daidzein by the heterol-
ogous expression of CYP enzymes, the 3’-ASDH gene was
amplified with and without 3’-DH gene. The recombinant
S. avermitilis strains proved to be a suitable natural host
for the expression of this artificial fusion enzyme.
Material and methods
Chemicals
Daidzein (7,4’-dihydroxyisoflavone) and 3’,4’,7-trihydrox-
yisoflavone (3’-ODI) used in this study were donated by
the Skin Research Institute, Amorepacific R&D Center,
South Korea. N,O-bis(trimethylsily)trifluoroacetamide
used for derivatization before gas chromatography/mass
spectrometry (GC/MS) analyses was obtained from
Fluka (Buchs, Switzerland). All other chemicals were of
the highest grade available.
Bacterial strain and culture condition
S. avermitilis MA4680 was obtained from the Korea
Collection for Type Cultures (KCTC; Daejeon, South
Korea). The strain was cultivated on R2YE medium con-
taining 10.3% sucrose, 1% glucose, 1% MgCl2 6H2O,
0.025% K2SO4, 0.5% yeast extract, 0.01% casamino acid,
0.57% TES, 0.005% K2HPO4, 0.03% CaCl2.2H2O,
0.003% L-proline, 2 ml of trace element solution and
5 mL of 1 N NaOH. Seed culture of S. avermitilis
MA4680 was generated in test tubes containing 5 mL
R2YE medium by shaking at 220 rpm for 3 days at 28°C.
Serial subculture was performed in 50 mL of the afore-
mentioned medium containing 50 μg of thiostrepton for
more than 3 days at 28°C.
Figure 1 Chemical structure and oxidative metabolite of daidzein by 3’-ASDH. This artificial fusion enzyme catalyzes the hydroxylation at
the 3’-position of daidzein B-ring with very high regio-selectivity.
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Gene manipulation
Chromosomal DNA from S. avermitilis MA4680 was
prepared using G-spinTM for Bacteria Genomic DNA
Extraction kit (iNtRON, Seungnam, South Korea). Plas-
mids from Escherichia coli strains were prepared using
the GeneAll DNA Purification System (Geneall Biotech-
nology, Seoul, South Korea). All polymerase chain reac-
tion (PCR) amplifications by were performed using Pfu
polymerase with GC II buffer (Takara Bio, Shiga, Japan).
Primers used in this study were commercially synthe-
sized by Cosmo Bioscience (Cosmo, Seoul, South Korea).
DNA of CYP105D7 and CYP102D1 with codon opti-
mized to suit the codon preference bias of E. coli were
fully synthesized by Bioneer (Daejeon, South Korea).
To construct the plasmid for the S. avermitilis system,
Streptomyces expression vector pIBR25 was used. Three
sets of over-expressing plasmids (pIBR25::3’-DH,
pIBR25::3’-ASDH and pIBRΔ3’-DH::3’-ASDH) and one
disruption plasmid (pIBRΔ3’-DH) were constructed. For
each set of primer designs an extra 50 nucleotides har-
boring the ribosomal binding site region was obtained
from the upstream region of the gene. The 3’-DH gene
was disrupted in S. avermitilis through homologous re-
combination. To inactivate 3’-DH, the 2.5 kb upstream
and 2.5 kb downstream fragments were amplified to-
gether with the apramycin resistance gene in the pUC19
vector. Plasmids were digested with restriction enzymes
and ligated into the Supercos1 vector. Transformants
carrying the single and double crossovers were distin-
guished by replica plaiting [24]. Finally, four recombin-
ant strains were prepared for the evaluation of daidzein
biotransformation by 3’-ASDH.
Artificial self-sufficient daidzein hydroxylase construction
by fusion arrangement and construction of recombinant
S. Avermitilis expressing 3’-ASDH
The reductase domain of CYP102D1 including the liker
domain (VRARQEHERTVFGAADLQTD) was PCR-
amplified from a synthetic CYP102D1 gene using a pri-
mer set. The PCR reaction conditions consisted of 30
cycles of denaturation for 1 min at 94 °C, annealing for
1 min at 68 °C and extension for 1.5 min at 72 °C. The
PCR product was cloned into the pET24ma(+) expres-
sion vector (Pasteur Institute, Paris, France) using the
restriction enzymes SacI and HindIII. The heme domain
(from Met1 to Thr402) of CYP105D7 which was chem-
ically synthesized after codon optimization complying
with the codon preferences of E. coli were digested with
EcoRI and SacI restriction enzymes (Bioneer, Seoul,
Korea). Correctly assembled DNA was cloned into the
pET-24ma(+) harboring reductase domain (from Asp478
to Ala1073) of CYP102D1.
To transform the protoplasts S. avermitilis, a previ-
ously detailed polyethylene glycol (PEG)-associated
transformation method was used [25]. The plasmid
(1 μg/μL in TE) was added to 0.1 mL of a protoplast
suspension containing approximately 102 protoplasts
generated by a 15-min lysozyme treatment. Five hundred
microliters of the protoplast buffer containing 30% (w/v)
PEG1000 (Sigma-Aldrich, St. Louis, MO) was added to
the mixture, which was carefully pipetted up-and-down.
This protoplast suspension was centrifuged after
addition of 300 μL of the protoplast buffer. The suspen-
sion was plated into a regeneration medium by gentle
shaking. After 16–18 h incubation, the plate was overlaid
with 10 μg/mL of thiostrepton.
Expression and purification of 3’-ASDH and its ultraviolet/
visible spectral features
E. coli BL21(DE3) cells containing 3’-ASDH was cul-
tured in Luria-Bertani (LB) medium containing 50 μg/
mL of kanamycin at 37 °C until the cell concentration
reached an optical density at 600 nm (OD600) of 0.6,
isopropyl-thio-β-D-galactopyranoside (IPTG) and δ-
aminolevlunic acid as heme precursor were added to a
final concentration of 0.25 mM, followed by growing for
overnight at 30 °C. Bacteria were harvested by centrifu-
gation and washed twice with phosphate buffered saline
(PBS), resuspended in 5 mL of a sonication buffer (pH
7.0) and disrupted by sonication. Disrupted soluble frac-
tions were collected by centrifugation and purified using
a Ni-NTA his-tag purification kit (QIAGEN Korea Ltd,
Seoul, South Korea). Purification was carried out utiliz-
ing the Ni-NTA resin. The Ni-NTA bound enzymes
were washed twice with 50 mM potassium phosphate
buffer (pH 7.0) containing 500 mM NaCl and 50 mM
imidazole, and enzymes were eluted with the same buf-
fer containing 200 mM imidazole. Finally, imidazole and
sodium chloride were removed by dialysis against
50 mM potassium phosphate buffer (pH 7.0). Purified
proteins were subjected to 10% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and
spectrophotometric analysis to measure carbon monox-
ide (CO)-binding activity [26]. Absorption spectra of
CO-bound recombinant CYP proteins after sodium di-
thionite reduction were measured by UV/vis spectrom-
etry (Thermo Lab Systems, Beverly, MA, USA) by
scanning wavelength from 400–500 nm [26]. The pro-
tein concentration was estimated using reduced CO ver-
sus reduced difference spectra. The 3’-ASDH protein
content was determined using an extinction coefficient
of 91.9 mM-1 cm-1 at 450 nm [26].
Determination of kinetic values of 3’-ASDH
NADPH oxidation was measured by the absorption de-
crease at 340 nm with UV/vis spectrometry (Thermo
Lab Systems, Beverly, MA, USA). A solution containing
160 μL of potassium phosphate buffer (pH 7.5), 10 μL of
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each substrate concentration solution in dimethyl sulf-
oxide (DMSO) and 20 μL of enzyme solution (10 μmol/
mL) was incubated for 5 min in a 96-well microplate.
The reaction was started by adding 10 μL of a 10 mM
NADPH solution. For determination of kinetic para-
meters, a substrate concentration range of 2.5–50 μM of
daidzein was used. All data were fitted to the Michaelis-
Menten equation by linear regression. As a reference
sample, NADPH consumption rates were measured in
the absence of substrate.
Substrate binding spectra of each CYP (Kd value)
Spectroscopic substrate binding spectra were obtained
as described previously [17]. A solution of substrate was
added to the enzyme solution to produce a final sub-
strate concentration of 2.5–100 μM. For the determin-
ation of Kd values, the reciprocal values of the
absorption difference between 394 nm and 418 nm were
plotted against the reciprocal values of the substrate
concentration. For calculation of the Kd value of the
enzyme-substrate, the experimental data were fitted to a
hyperbola curve (y = ax(b + x)-1) by a nonlinear regres-
sion procedure based on the Durbin-Watson algorithm
in SigmaPlot software (Systat, San Diego, CA).
Resting cell assay of E. Coli BL21(DE3) expressing 3’-ASDH
in the bioconversion of daidzein
Cells were harvested and washed twice with 50 mL of
PBS buffer. And the cells were resuspended in potassium
phosphate buffer (100 mM, pH 7.0) containing 1% of
glucose. The initial substrate stock solution was pre-
pared by dissolving daidzein (24.5 mg) into the DMSO
and diluted to reaction concentration (100 μM) using
DMSO: MeOH (50:50) solvent. Whole cell reactions
were initiated by the addition of the substrate at 37 °C in
a shaker (200 rpm) for 24 h. The reaction was quenched
by the addition of same volume of ethyl acetate to the
reaction, followed by vigorous vortexing. The mixtures
were centrifuged at 13,000 rpm for 10 min, after which
the upper layer containing any remaining substrate and
products (oraganic layer) was extracted, followed by
evaporation of the supernatant using a vacuum (Bio-
Tron, Bucheon, South Korea). The sample was subse-
quently used for GC/MS structural and quantitative
analyses.
Resting cell assay of recombinant S. Avermitilis in the
bioconversion of daidzein
Each recombinant S. avermitilis cells harvested from
50 mL of culture broth were washed twice with potas-
sium phosphate buffer (50 mM, pH 7.2). After centrifu-
gation (13,000 rpm, 10 min), 5 g of cells (wet wt.) were
added to 50 mL of potassium phosphate buffer
(100 mM, pH 7.2) with 0.1 mM of final substrate
concentration in DMSO:MeOH (50:50). The mixture
containing 50 mL in 250 mL flask was incubated in a
shaker at 200 rpm for 72 h at 28 °C and the reaction
mixture was extracted with ethylacetate (JUNSEI, Japan).
The extracted sample was evaporated in a centrifugal
vacuum concentrator (BioTron, South Korea). And the
solvents in DMSO:MeOH (50:50) was added in the reac-
tion with the final volumetric ratio from 0% to 40% in
order to examine the biotransformation conversion de-
pending on organic solvent concentrations.
GC/MS analysis of products
For structural analysis of oxidative metabolites of daid-
zein, samples extracted with ethylacetate were evapo-
rated to dryness and dissolved in 100 μL methanol. The
same volume of 0.5 M NH4CO3 and 2 M KCl was added
to each sample, and the mixture was centrifuged at
room temperature, after which the supernatant was
transferred to a new vial for derivatization. To protect
hydroxyl groups, reaction products were derivatized
using N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA)
by heating at 60 °C for 60 min. GC/MS was performed
using a Finnigan MAT system (Gas chromatograph
model GCQ, HP 19091j-433; Thermo Labsystems, USA)
connected to an ion trap mass detector. The BSTFA
derivatives were separated through a non-polar capillary
column (5% phenyl methyl siloxane capillary
30 m× 250 nm i.d., 0.24 μm film thickness, HP-5) con-
taining a linear temperature gradient (for fatty acids: at
100 °C 0.5 min, 5 °C/min to 200 °C, hold for 5 min,
10 °C/min to 250 °C, hold for 3 min; for cyclic compounds:
at 60 °C 1 min, 30 °C/min to 250 °C, hold for 10 min,
1 °C/min to 275 °C, hold for 3 min). The injector port
temperature was 250 °C. Mass spectra were obtained by
electron impact ionization at 70 eV, and scan spectra
were obtained within the range of 100–600 m/z. Selected
ion mode (SIM) was used for the detection and fragmen-
tation analysis of major products.
Homology modeling of 3’-ASDH
Homology modeling of 3’-ASDH was performed by
combinations of heme domain of CYP105D7 and reduc-
tase domain of CYP102D1. The homology model of
CYP105D7 was constructed using 3ABB [27], a crystal
structure of CYP105D6 involved in filipin hydroxylation,
and CYP102D1 was constructed using 3hf2a, a crystal
structure of CYP102A1 variant from the PDB database
as a template. The predicted 3D structure was con-
structed based on a comparative homology modeling
method using the Genefold and Composer programs
from the SYBYL software package (Tripos Associates,
St. Louis, MO). The initial state model was energy-
minimized by the conjugate gradient method at an en-
ergy gradient norm of 0.01 kcal/mol.
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Results
Fusion-mediated self-sufficient construction of CYP105D7
with the reductase domain of CYP102D1
A recent study described the functional expression of a
self-sufficient P450, CYP102D1, from S. avermitilis in E.
coli [15]. Since the original gene coding CYP102D1
could not be successfully expressed in E. coli, the gene
was chemically synthesized following codon optimiza-
tion complying with the codon preferences of E. coli.
The reductase domain consisting of the di-flavin binding
domain (FAD/FMN) has linker sequences from Val458
and the coding synthetic DNA was first cloned into the
expression vector pET24m(a). Target DNAs encoding
daidzein hydroxylases were amplified with each specific
primer and cloned into the pET24m(a)-CYP102D1 re-
ductase (Figure 2). Especially, the sav7469 gene coding
3’-DH was not solely expressed in E. coli well; the codon
optimized sav7469 gene missing stop codon based on
E. coli codon bias was also used in the artificial self-
sufficient P450 construction. Finally, the 3’-ASDH fu-
sion protein was prepared by two synthetic DNA gene
manipulations (Figure 2).
Expression of artificial fusion proteins and their
spectroscopic characterizations
Figure 3A summarizes the expression of the constructed
fusion protein. The protein was abundantly expressed as
a soluble fraction yielding 19.2 mg/L of 3’-ASDH, and
His-tag purified protein was prepared for in vitro
reaction as a reconstituted system. The purified fusion
protein displayed a single protein band corresponding to
a theoretical molecular weight of about 110 kDa, which
was deduced by taking the reductase domain of
CYP102D1 as 65 kDa, and finally concentrated (×1500)
to yield approximately 3.0 mg/mL (1.0 μM) (Figure 3A).
To examine the functional folding of the purified pro-
tein in the ferric state (reduced form), UV/vis spectros-
copy was utilized. In general, a cysteine-thiolate ligand
coordinated to the heme iron atom of CYP regulates any
spectroscopic and catalytic properties. Figure 3B shows
the absorption spectra of the fusion protein. Absorption
spectroscopy of the purified artificial self-sufficient pro-
tein in its oxidized form (dashed line) and reduced form
(dash-dotted line) revealed general features of bacterial
CYPs. The oxidized form of spectra shows typical spec-
tra of self-sufficient CYP enzyme with Soret peak at
419 nm, an α-band at 567 nm, and and unresolved β-
band due to the overlap with a broad shoulder in the
440–490 nm regison. This shoulder was interpreted as
the flavin prosthetic groups. The 440–490 nm shoulder
disappears upon addition of sodium dithionite owing to
reduction of the flavins [28]. In addition, the absorption
spectra of the reduced-CO oxidized forms are indicated
in the inset. The CO-difference spectra resulting from
the insertion of CO gas into a reduced state by sodium
dithionite revealed that the heme Soret absorption max-
imum was at 450 nm [19]. As the reductase domain of
CYP102D1 uses NADPH as an electron donating source,
the constructed fusion enzyme used NADPH preferably
(approximately 500 μmol cyt c/min/μmol CYP).
Daidzein hydroxylation reaction catalyzed by 3’-ASDH
fusion enzyme
The activity of 3’-ASDH fusion enzyme was measured
using daidzein as a substrate in order to validate the effi-
ciencies of fusion orientations with the natural three-
component system. Previously, the CamA/B redox proteins
from Pseudomonas putida were proven to be alterna-
tive electron transferring proteins [20]. Thus, the re-
constituted 3’-DH and CamA/B enzyme activity was
compared to that of 3’-ASDH. GC-MS assay of daidzein
hydroxylation activity measured the hydroxylated pro-
ducts. The kinetic parameters of the 3’-ASDH enzyme
were incredibly dominant over those of the reconstituted
3’-DH-camA/B system (Table 1), indicating that the fu-
sion arrangement in a single polypeptide was absolutely
efficient for inter-molecular electron transfer, rather than
intra-molecular electron transfers, and was sufficient for
CYP activity. As mentioned before, an excellent benefit
of the fusion arrangement is that the covalent linkage
presumably stabilizes the interaction between P450 and
redox protein, enhancing electron transfer efficiency. As
such, one would expect this to improve the catalytic
Figure 2 Design of artificial self-sufficient daidzein
hydroxylases by heme domain swapping with self-sufficient
CYP102D1 from Streptomyces avermitilis. The reductase domain
consisting of di-flavin binding domain (FAD/FMN) has linker
sequences from Val458 and the coding synthetic DNA was first
cloned into the expression vector pET24m(a). And the target DNAs
coding daidzein hydroxylases were amplified with each specific
primer and coned into the pET24m(a)-CYP102D1 reductase.
Choi et al. Microbial Cell Factories 2012, 11:81 Page 5 of 10
http://www.microbialcellfactories.com/content/11/1/81
activity in terms of kcat, whereas the substrate specificity
would not be changed significantly. The experimental
results supported these expectations; the Km values of
the reconstituted 3’-DH and 3’-ASDH proteins were
quite similar in the range of approximately 20 μM,
whereas the catalytic activity (kcat) of the fused enzymes
was significantly different from that of 3’-DH alone. The
kcat values of 3’-ASDHs were approximately 342 nmol/
min-1/nmol of CYP, which is about 24-fold higher than
that of the reconstituted 3’-DH-camA/B system. These
results indicate that the binding affinity (Kd =15.3 μM)
between the heme domain of the DH enzyme and the
substrate daidzein was not affected by fusion arrange-
ment, whereas artificial fusion arrangements allowed ef-
fective intra-molecular electron transfer from NADPH
to the heme domain through reductase, confirming our
expectations. Effective electron transfer between CYP
and reductase existing in different molecules of a fusion
monooxygenase can occur if the two molecules are
dimeric partners, but this type of electron transfer can-
not be discriminated from intramolecular transfer if the
dissociation constant of the dimer is very small [15].
Such intramolecular electron transfer has been reported
for naturally-occurring bacterial fusion CYP enzymes
such as CYP102A family members catalyzing fatty acid
hydroxylation.
Quantitative and structural analysis of reaction products
using high-performance liquid chromatography (HPLC)
and GC/MS
The resting cell assay using 3’-ASDH expressing E. coli
BL21(DE3) revealed unique reaction products. The iden-
tification of oxidative metabolite was performed with
GC/MSn (Figure 4A). Mass analysis of daidzein revealed
a molecular ion mass of 398 m/z, and each monohy-
droxylated product was observed at 486 m/z, resulting
in a 88 m/z increase due to incorporation of molecular
oxygen (+16 m/z) after BSTFA derivatization (+72 m/z)
(Figure 4B). These values agree with the mass analysis
patterns of the corresponding reference chemicals. The
hydroxylated products were identified as 3’-ODI, which
was mono-hydroxylated form of daidzein at the ortho
position of 4’-hydroxyl group at the B-ring. Mass spec-
tral analysis revealed that each had a molecular ion mass
of 486 m/z after BSTFA derivatization, which was
exactly the same as those of the reference compounds.
This result demonstrates that our previous understand-
ing of daidzein hydroxylase reserves regio-selectivity
after fusion arrangement with reductase domain regard-
less of catalytic activity for aromatic compounds such as
ortho-hydroxylated daidzein.
Figure 3 Expression and UV-visible absorption spectra of 3’-ASDH. (A) SDS/PAGE analysis of total cell protein content as well as purified
protein containing the His-6 tag; the lanes, from the left, are total cell protein content after induction, total soluble protein content, purified
protein content and total cell protein content before IPTG and protein marker, respectively. (B) UV-visible absorbance spectra of purified 3’-ASDH
fusion protein revealed spectral features characteristic of CYPs; Dashed line: oxidized form, Dotted line: Reduced form with dithionite. Solid line:
CO-difference spectra; Inserted figure: CO-difference spectra of 3’-ASDH.
Table 1 Comparison of kinetic parameters of P450s with





Km [μM] 21.8 ± 3.6 20.5 ± 5.1
kcat 15.0 ± 2.1 342.3 ± 53.6
[min-1]
k cat/K m 0.7 ± 0.4 16.8 ± 4.6
[μM-1min-1]
Coupling efficiency (%) < 55 < 72
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Development of recombinant S .Avermitilis host system
for heterologous expression of 3’-ASDH
The resting cell assay in E. coli revealed that 3’-ASDH
expressed in E. coli did not produce the expected con-
version (approximately 5%) when 100 μM of daidzein
was used as an initial substrate concentration, although
purified 3’-ASDH enzyme showed very high catalytic
activity.
Previously we reported that S. avermitilis strain is
highly active and regiospecific to daidzein and genistein,
producing monohydroxylated products [20,29,30]. The
sav7469 gene encoding 3’-DH, among the 33 CYPs of
S. avermitilis, dominantly catalyzed the regio-specific
hydroxylation of daidzein to produce 3’-ODI. These
results suggested that S. avermitilis is a very good reac-
tion host for daidzein biotransformation by virtue of
having the genomic encoding capacity for 3’-DH and its
natural redox proteins. Thus, we presently sought the
heterogeneous expression of 3’-ASDH in S. avermitilis
and biotransformation of daidzein using recombinant
strains.
Four recombinant S. avermitilis strains were con-
structed to compare the productivity of 3’-ODI, S. aver-
mitilisΔ3’-DH, S. avermitilis Δ3’-DH::3’-ASDH, S.
avermitilis::3’-DH and S. avermitilis:: 3’-ASDH (Table 2).
As the S. avermitilis wild-type genome encodes 3’-DH
(sav7469), the wild-type alone could convert daidzein
into 3’-ODI at a rate of 6.7%. After deletion of the
sav7469 gene, almost 50% of the wild-type activity was
Figure 4 (A) Gas-chromatography analysis patterns of monohydroxylated product. A major oxidative metabolite of daidzein was separated
and identified as 3’,4’,7-trihydroxyisoflavone (3’-ODI) based on the retention times and mass (m/z) values comparing with reference compound.
(B) Mass spectral analysis revealed that each had a molecular ion mass of 486 m/z after BSTFA derivatization, which was exactly the same as
those of the reference compounds. As a result, 3’-ASDH oxidized daidzein to mono-hydroxylated product of daidzein with very high catalytic
activity.
Table 2 Comparison of conversions of recombinant E. coli
and S. avermitilis for 3’-ODI production
Strains Conversion Productivity Fold-
change(%)* (μg/hr/g cells)
E. coli BL21::ASDH 2.1 2.9 0.3
Wild type S. avermitilis 6.7 9.3 1.0
Δ3’-DH 3.4 4.7 0.5
Δ3’-DH::3’-ASDH 15.5 21.4 2.3
Wild type::3’-DH 22.0 30.5 3.3
Wild type:: 3’-ASDH 34.6 48.4 5.2
*100 μM of substrate was used as an initial concentration at each reaction.
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retained, whereas strain Δ3’-DH::3’-ASDH restored con-
version and the conversion yield was 2.3-fold higher
than that of the wild-type, suggesting that 3’-DH is re-
sponsible for daidzein hydroxylation at the 3’-position.
Further investigation of the productivity by S. avermitilis
Δ3’-DH::3’-ASDH strain revealed that 3’-ASDH was
functionally expressed in S. avermitilis and could pro-
duce 3’-ODI with a conversion rate of 15.5% without
any background influence by 3’-DH in its genome. These
results indicated that artificial self-sufficient fusion
enzymes could work in the S. avermitilis recombinant
strain, and its catalytic activity in terms of product pro-
duction was increased by more than 4 times along with
enzyme kinetic parameters.
Computational structure prediction of 3’-ASDH and
verification of electron transfer distance
In this study, daidzein was hydroxylated by oxidation
catalyzed by the fusion enzyme, wherein an additional
diflavin containing the reductase responsible for transfer
of a reducing equivalent from NADPH to CYP heme
was additionally fused including original linker
sequences. Since this orientation of the electron transfer
system was not native, the distance between the heme
iron and flavin was very important regarding enzyme ac-
tivation and coupling efficiency. Here, we used an ori-
ginal linker domain in the sequence of CYP102D1, so as
not to change its natural folding or the flexibility of
linker peptides (VRARQEHERTVFGAADLQTD). To
verify electron transfer, we generated computational
models of both native CYP102D1 and 3’-ASDH, and
measured the heme-FMN distances.
Computational simulation revealed that the ASDH en-
zyme had a modular structure in which FAD/FMN and
NADPH binding sites were situated distinctively at the
N-terminal, central and C-terminal regions. As shown in
Figure 5, both the heme and flavin structures were
incorporated together in the protein. The flavin struc-
ture was located close to the non-native heme iron cen-
ter within a calculated distance of 22.4 Å (Figure 5B),
which was very reasonable for the inter-molecular trans-
fer of electrons based on the distance of 23.6 Å
(Figure 5A) between FMN and heme center in the native
CYP102D1 enzyme structure [17]. Although the con-
formational changes induced by interaction between re-
ductase and CYP or substrate were not exactly predicted
or calculated, sufficient electron transfer took place and
enzymatic reactions occurred very quickly. Further
investigations of this CYP-flavoprotein system, its elec-
tron transfer rate, and the coupling efficiency between
the reconstituted and fused systems are underway.
Discussion
In synthetic chemistry, many synthetic strategies for
carbon-hydrogen (C-H) oxidation rely on a reactive
intermediate that involves subtle differences in C-H
bond strength to achieve regio-selectivity. Owing to the
large number of C-H bonds in most bioactive chemicals,
identifying a reagent that can specifically react at one C-
H bond is usually difficult. Thus, concerning regio-
selectivity, enzymatic oxidation catalyzed by P450s on
non-activated carbon is a great challenge in modern in-
dustrial processes such as drug development and bio-
fuel generation.
As a model system, we demonstrated the regio-specific
hydroxylation of daidzein of which their biological activ-
ities or functions were greatly affected to obtain more
than 30 times higher anti-oxidant capacity by hydroxyl-
ation on its 3’-position using an artificial self-sufficient
enzyme [31,32]. Here, we solved the requirement for
Figure 5 Computational simulation revealing coincident incorporation of heme and flavin structures in the protein. Here, the flavin
structure was located close to unnative heme iron center within a calculated distance of 22.4 Å (Figure 5B), which is very reasonable for the inter-
molecular transfer of electrons based on the distance of 23.6 Å (Figure 5A) between FMN and heme center in the native CYP102D1 enzyme
structure.
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redox proteins, which is considered to be a bottle neck
in CYP enzyme reaction, by fusion construction. As the
synthetic 3’-ASDH gene was successfully expressed in E.
coli after the codon optimization process, we were able
to compare its catalytic activity with that of the 3’-DH-
CamAB system [25]. The fusion-enabled enzyme dis-
played a higher turn-over rate and higher conversion
without any alterations of regio-specificity and substrate
specificity, compared with the parent enzyme.
Use of E. coli as a biotransformation system carries
many limitations. For example, the bacteria require ex-
ogenous transfer of electron from redox proteins such as
CamA and CamB [30]. In addition, E. coli are very sus-
ceptible to the killing action of organic solvents used in
dissolving substrate in the reaction [33,34]. As an alter-
native organism, Streptomyces preserves high redox po-
tential during enzymatic reactions; the organism has
proved useful for production of various antibiotics or
secondary metabolites, which need many redox proteins.
As well, Streptomyces is less toxically affected by organic
solvents [35]. These attributes have been exploited in
the use of Streptomyces as a CYP reaction host for daid-
zein biotransformation. Furthermore, it is possible to
dissolve substrate in the reaction up to more than final
volume of 1 mM when using 10% of DMSO:MeOH
(50:50) mixed solvents without any inhibition of cell
growth or cell toxicity (Table 3) [29]. With these charac-
teristics in combination with gene manipulation systems
like over-expression and gene disruption, S. avermitilis
could be a strong host for biotransformation of daidzein
[29].
Although S. avermitilis has been used for the heterol-
ogous expression or secretion of several polypeptides of
bacterial and eukaryotic origin, heterologous genes usu-
ally need genetic modification in ribosomal binding sites
or in its full DNA sequences for successful expression.
However, 3’-DH and reductase domain originate from S.
avermitilis and no genetic modifications was necessary
for expression. Disruption of sav7469 (3’-DH) regarded
as a major factor in 3’-ODI production and overexpres-
sion of 3’-ASDH in this deletion mutant finally proved
that it is well-expressed in its original host and operates
in daidzein biotransformation more efficiently as well.
Although only 3’-DH was not operative in daidzein hy-
droxylation, considering that S. avermitilisΔ3’-DH
retained some activity for 3’-ODI production, the con-
version of daidzein using S. avermitilis::3’-ASDH strain
increased more than 4-times. Compared to the conver-
sion rate of <5% in E. coli biotransformation, this is an
absolutely increased value. This yield is very close to the
levels that are attractive for industrial applications.
This study regarding the combination of enzyme engin-
eering and S. avermitilis host development opens up the
possibility of actinomycetes utilization as a recombinant
expression host system for the production of biologically
important compounds using fusion P450 proteins.
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